By training on multi-scale data from lab, pilot, and production runs, AI can predict how parameters like mixing and oxygen transfer will change at larger volumes. This enables teams to proactively adjust processes, moving from 'hoping' a process scales to 'knowing' it will.

The future of bioprocess development involves using AI on high-throughput data for predictive modeling. This, combined with in silico simulations (digital twins), will allow scientists to understand underlying biological mechanisms, not just identify optimal conditions, dramatically accelerating optimization.

By analyzing a model predicting Alzheimer's, Goodfire discovered it relied on the length of cell-free DNA fragments—a previously overlooked signal. This demonstrates how interpretability can extract new, testable scientific hypotheses from high-performing "black box" models.

The primary obstacle to creating sophisticated AI models of cells isn't the AI itself, but the data. Existing datasets often perturb only one cellular variable at a time, failing to capture the complex interactions that arise from simultaneous changes. New platforms are needed to generate this multi-dimensional data.

The primary value of AI in bioprocessing is not just automating tasks, but analyzing process data to predict outcomes. This requires a fundamental shift in capital equipment design, focusing on integrating more sensors and methods to collect far more granular data than is standard today.

Resist the urge to apply LLMs to every problem. A better approach is using a 'first principles' decision tree. Evaluate if the task can be solved more simply with data visualization or traditional machine learning before defaulting to a complex, probabilistic, and often overkill GenAI solution.

For AI systems to be adopted in scientific labs, they must be interpretable. Researchers need to understand the 'why' behind an AI's experimental plan to validate and trust the process, making interpretability a more critical feature than raw predictive power.

It's tempting to think you can intuit the few factors a decision hinges on. This is often wrong. Complex systems have non-obvious leverage points. The process of building an explicit model reveals which variables have the most impact—a discovery you can't reliably make with intuition alone.

To optimize a complex biosimilar profile with many correlated attributes like glycoforms, use Mahalanobis distance. It calculates a single multivariate distance to the target profile, correctly accounting for inter-glycoform correlations, providing an objective, data-driven method for ranking experimental outcomes.